- Investing Ideas
- /
- Norwegian Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Norwegian Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
2
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
2 companies
ArcticZymes Technologies
Market Cap: NOK 855.4m
A life sciences company, develops, manufactures, and commercializes recombinant enzymes for use in molecular research, in vitro diagnostics, and biomanufacturing in Norway, Germany, Lithuania, France, Italy, the United Kingdom, rest of Europe, the United States, and internationally.
AZT
NOK 16.50
7D
-2.7%
1Y
-37.7%
Navamedic
Market Cap: NOK 381.5m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
NAVA
NOK 21.60
7D
0.5%
1Y
-37.0%